跳至主要内容
临床试验/NCT04213157
NCT04213157已完成不适用

Evaluation Trifecta and Pentafecta Outcomes of Patients Underwent Laparoscopic Partial Nephrectomy for cT1 Renal Tumor

Samsun Liv Hospital2 个研究点 分布在 1 个国家目标入组 292 人开始时间: 2019年3月15日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
292
试验地点
2
主要终点
Operation time

研究概览

简要总结

The aim of the study is to evaluate trifecta and pentafecta outcomes for laparoscopic partial nephrectomy (LNP) in patients with clinical T1N0M0 renal tumor.

详细描述

From November 2009 to August 2018 a total of 292 patients who underwent LPN by global ischemia were included in the study. The patients were allocated into two groups according to the tumor size; T1a (≤ 40 mm, n=215), T1b (41-70 mm, n=77). Demographics features, clinical tumor characteristics, intraoperative and postoperative outcomes were analyzed. A negative surgical margin, warm ischemia time (WIT) < 20 min and no postoperative complications (Clavien-Dindo ≥ grade 3) were accepted to achieve the trifecta outcomes. Pentafecta has defined as trifecta criteria plus >90% preservation of estimated glomerular filtration rate (eGFR) and no stage upgrade of chronic kidney disease 12 months after LPN. Univariable and multivariable analysis were used to identify factors predicting trifecta and pentafecta achievement.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Retrospective

入排标准

年龄范围
18 Years 至 82 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Functioning contraleteral kidney
  • Patients with complete data
  • Patients with single renal tumor on the effected side
  • Patients who approved the written consent form

排除标准

  • The patients with bilateral renal tumors (n=8, 16 LPNs)
  • solitary kidney (n=8)
  • horseshoe kidney (n=4)
  • pelvic ectopic kidney (n=2)
  • graft kidney (n=2)
  • those with multiple renal tumors in a single kidney (n=3) or with > 7 cm renal tumor (n=6)
  • Patients who were operated on for colon cancer (n=4), prostate cancer (n=2), endometrial cancer (n=1) or adrenal mass (n=2) within the first year after LPN

结局指标

主要结局

Operation time

时间窗: at the end of the surgery

time from onset to complete of surgery

Blood loss

时间窗: at the end of the surgery

amount of bleeding during surgery (mL)

CKD stage upgrading

时间窗: up to 1 year postoperatively

evaluation of preoperative and postoperative renal functions according to chronic kidney disease stages

Oncological outomes

时间窗: up to the last clinical control (months)

Presence or absence of local and/or distal tumor recurrence

warm ischemia time

时间窗: at the and of the surgery

The clamp time of the renal artery and vein which is required to complete tumor excision and renorrhaphy

intraoperative complication

时间窗: at the end of the surgery

abnormal problmes that may be seen during surgery

Postoperative complication

时间窗: up to 3 months

abnormal problmes that may be seen after surgery and require additional intervention, treatment or follow-up

functional outcomes

时间窗: up to 1 year postoperatively

serum creatinine level and estimated glomerular filtration rate

surigcal margin status

时间窗: up to 1 month postoperatively

presence or absence of tumors at the surgical margin

Relative decrease in renal function

时间窗: up to 1 year postoperatively

Comparison of preoperative and postoperative renal functions according to numerical and percentile values

次要结局

未报告次要终点

研究者

发起方
Samsun Liv Hospital
申办方类型
Other
责任方
Principal Investigator
主要研究者

Mehmet Necmettin Mercimek

Principal Investigator

Samsun Liv Hospital

研究点 (2)

Loading locations...

相似试验